Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

As seen in the DESTINY-Breast06 trial, approximately 20-25 percent of hormone receptor (HR)-positive, HER2-negative breast ...

A $10.3 million grant from the California Institute for Regenerative Medicine (CIRM), the state’s stem cell agency, will fund ...

President Donald Trump has targeted transgender and nonbinary people with a series of executive orders since he returned to office.

So, you're mad at the National Institutes of Health, even though they were just responding to "Warp Speed" orders and complied. So, let's ...

Thousands of school dropout girls between 11 and 14 years, and anti-vaxxers who have been spreading rumours are the main challenges for the success of the upcoming vaccination drive scheduled to start ...

A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

A recent study carried out by a research team from the Paul-Ehrlich-Institut investigated the immunomodulating properties of ...

A new treatment for cellulite is being offered in the Quad Cities. Jennifer R. Cassatt, a Physician Assistant with MercyOne Genesis Plastic Surgery explains the Aveli system, which is a minimally ...

Daniel Rubin, PharmD, BCOP, discussed a study showing how a clinical decision support tool can improve the documentation of biomarker results in cancer care.